---
$id: https://graph.org.ai/products/commodity/51131645
$type: Product
source: UNSPSC
code: "51131645"
title: "Moxicoumone"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Moxicoumone

**UNSPSC Code**: 51131645
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticoagulant agent with the molecular formula C22H30N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IG2442S013, chemically known as 4-methyl-5,7-bis(2-morpholinoethylethoxy)coumarin but generally known as moxicoumone, which bears US NIH Compound Identifier 65686. European Medicines Agency schedules Moxicoumone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09084MIG. The term MOXICOUMONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). MOXICOUMONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule moxicoumone under HS 29349990 and SITC 51579. As of Q4 2014, MOXICOUMONE remains the US FDA Preferred Term for this commodity. Moxicoumone bears US NLM identifiers UMLS ID C0066835 and NCI Concept Code C66210. SMILES: O1CCN(CC1)CCOC1C2C(OC(=O)CC2C)CC(OCCN2CCOCC2)C1.

